8. Contraceptions Flashcards
Name types of contraceptive methods (6)
- Physiological
- Barrier methods
- Hormonal
- Copper IUD
- Surgical
- Emergency Postcoital Contraception (EPC)
Name Physiological contraceptive methods (5)
- Withdrawal/coitus interruptus
- Rhythm method/calendar/mucus/symptothermal
- Lactational amenorrhea
- Chance – no method used
- Abstinence of all sexual activity
Name barrier contraceptive methods (6)
- Condom alone
- Spermicide alone
- Sponge – Parous - Nulliparous
- Diaphragm with spermicide
- Female condom
- Cervical cap – Parous - Nulliparous
Name hormonal contraceptive methods (7)
- OCP
- Nuva Ring®
- Transdermal (Ortho Evra®)
- Depo-Provera®
- Progestin-only pill (Micronor®)
- Mirena® interauterine system (IUS)
- Jaydess® interauterine system (IUS)
Name surgical contraceptive methods (2)
- Tubal ligation
- Vasectomy
Name Emergency Postcoital Contraception (EPC) (4)
- Yuzpe® method
- “Plan B” levonorgestrel only
- Postcoital interauterine system IUD
- Ella
Name: Combined Oral Contraceptive Pills (5)
- progestin
- estrogen
- most contain low dose ethinyl estradiol (20-35 µg) plus progestin (norethinedrone, norgestrel, levonorgestrel, desogestrel, norgestimate, drospirenone)
- failure rate (0.3% to 8%) depending on compliance
- monophasic or triphasic formulations (varying amount of progestin throughout cycle)
Describe action of progestin as Combined Oral Contraceptive Pills (5)
- prevents LH surge
- suppresses ovulation
- thickens cervical mucus
- decreases tubal motility
- decidualizes endometrium
Describe action of estrogen as Combined Oral Contraceptive Pills (2)
- suppresses FSH and follicular development
- causes endometrial proliferation
Describe: Transdermal (Ortho Evra®) (6)
- continuous release of 6 mg norelgestromin and 0.60 mg ethinyl estradiol into bloodstream
- applied to lower abdomen, back, upper arm, buttocks, NOT breast
- worn for 3 consecutive weeks (changed every wk) with 1 wk off to allow for menstruation
- as effective as OCP in preventing pregnancy (>99% with perfect use)
- may be less effective in women >90 kg
- may not be covered by drug plans
Describe: Contraceptive Ring (Nuva Ring®) (6)
- thin flexible plastic ring
- releases etonogestrel 120 µg/d and estradiol 15 µg/d
- works for 3 wk then removed for 1 wk to allow for menstruation
- as effective as OCP in preventing pregnancy (98%)
- side effects: vaginal infections/irritation, vaginal discharge
- may have better cycle control; i.e. decreased breakthrough bleeding
Describe Starting Hormonal Contraceptives (4)
- thorough history and physical exam, including blood pressure and breast exam
- can start at any time during cycle but ideal if within 5 d of last menstrual period (LMP)
- follow-up visit 6 wk after hormonal contraceptives prescribed
- pelvic exam not required as STI screening can be done by urine and pap smear screening does not start until >21 yr
Name advantages: Combined Estrogen and Progestin Contraceptive Methods (10)
- Highly effective
- Reversible
- Cycle regulation
- Decreased dysmenorrhea and heavy menstrual bleeding (less anemia)
- Decreased benign breast disease and ovarian cyst development
- Decreased risk of ovarian and endometrial cancer
- Increased cervical mucus which may lower risk of STIs
- Decreased PMS symptoms
- Improved acne
- Osteoporosis protection (possibly)
Name estrogen-related side effects: Combined Estrogen and Progestin Contraceptive Methods (8)
- Nausea
- Breast changes (tenderness, enlargement)
- Fluid retention/bloating/edema
- Weight gain (rare)
- Migraine, headaches
- Thromboembolic events
- Liver adenoma (rare)
- Breakthrough bleeding (low estradiol levels)
Name Progestin-related side effects: Combined Estrogen and Progestin Contraceptive Methods (9)
- Amenorrhea/breakthrough bleeding
- Headaches
- Breast tenderness
- Increased appetite
- Decreased libido
- Mood changes
- HTN
- Acne/oily skin*
- Hirsutism*
How can androgenic side effects of progestin-related contraceptive method may be minimized? (4)
by prescribing formulations containing
- desogestrel
- norgestimate
- drospirenone
- or cyproterone acetate
Name absolute contraindications: Combined Estrogen and Progestin Contraceptive Methods (9)
- Known/suspected pregnancy
- Undiagnosed abnormal vaginal bleeding
- Prior thromboembolic events, thromboembolic disorders (Factor V Leiden mutation; protein C or S, or antithrombin III deficiency), active thrombophlebitis Cerebrovascular or coronary artery disease
- Estrogen-dependent tumours (breast, uterus)
- Impaired liver function associated with acute liver disease
- Congenital hypertriglyceridemia
- Smoker age >35 yr
- Migraines with focal neurological symptoms (excluding aura)
- Uncontrolled HTN
Name relative contraindications: Combined Estrogen and Progestin Contraceptive Methods (7)
- Migraines (non-focal with aura <1 h)
- DM complicated by vascular disease
- SLE
- Controlled HTN
- Hyperlipidemia
- Sickle cell anemia
- Gallbladder disease
What can decrease efficacy of combined estrogen and progestin contraceptive method, requiring use of back-up method? (6)
- Rifampin
- phenobarbital
- phenytoin
- griseofulvin
- primidone
- St. John’s wort
Describe: Fetal abnormalities if conceived on OCP (1)
No evidence of fetal abnormalities if conceived on OCP
Describe use of oral contraceptive pill and nursing infant and breastfeeding (3)
- No evidence that OCP is harmful to nursing infant
- but may decrease milk production;
- not recommended until 6 wk postpartum in breastfeeding and non-breastfeeding moms, ideally ≥3 mo postpartum if BF
Describe link between irregular breakthrough bleeding and OCP (2)
- Irregular breakthrough bleeding often occurs in the first few months after starting OCP
- usually resolves after three cycles
Name Active Compounds (estriol and progestin derivative): Alesse® (2)
- 20 µg ethinyl estradiol
- 0.5 mg levonorgestrel
Name advantages: Alesse® (2)
- Low dose (20 µg) OCP
- Less estrogen side effects
Name disadvantages: Alesse® (2)
- Low-dose pills can often result in breakthrough bleeding
- If this persists for longer than 3 mo, patient should be switched to an OCP with higher estrogen content
Name Active Compounds (estriol and progestin derivative): Tri-cyclen® (3)
- 35 µg ethinyl estradiol
- 0.180/0.215/0.250 mg norgestimate
- Triphasic oral contraceptive (graduated levels of progesterone)
Name advantages: Tri-cyclen® (1)
Low androgenic activity can help with acne